Light-based innovation for the biosciences

After receiving his undergraduate degree from the University of Oxford and PhD from the University of Bristol, Dr Reynolds was a Research Fellow at the MGH Cancer Center/ Harvard Medical School and then a Research Scholar at the University of California, San Francisco, before moving to St Andrews in 2007. His lab is interested in identifying those molecular changes which drive disease with particular emphasis on 1) cancer resistance mechanisms to therapeutic drugs and 2) the mechanobiology of kidney podocytes in health and disease. His lab uses biochemistry, molecular biology and cell biology approaches to investigate the nature and context of these factors and how they impact upon human health.

Research areas:

  • Cellular medicine
  • Systems pathology
  • Cancer drug resistance
  • Podocyte mechanobiology

Paul Reynolds research group